Oxford Nanoimaging (ONI) recently launched the Aplo Scope super-resolution microscope that pushes imaging precision to 20 nm. The Aplo Scope integrates lasers, optics, chemistry, and software in a compact footprint, helping researchers capture and analyze molecular interactions at the nanoscale. With its user-friendly design and portability, ONI aims to simplify super-resolution microscopy and potentially reduce…
How data-savvy are you in drug discovery?
Hey there, drug discovery professionals: Ever wondered where you stand in the grand scheme of drug discovery data-savviness? We’ve created a short quiz to help you get an idea. Drug discovery and development is an increasingly data-intensive field, underscoring the need for data science to be a core drug discovery discipline. The industry has taken…
Ready, set, analyze: Amazon Omics unveils new Ready2Run workflows
Amazon Web Services (AWS) recently announced a significant expansion of Amazon Omics at the annual AWS Life Sciences Executive Symposium in Boston. Amazon Omics, which the company introduced last year, helps life science organizations to store, query and analyze genomic, transcriptomic and other omics data. While other tools such as Qlucore Omics Explorer, Genospace, StrandOmics,…
Harnessing the untapped potential of legacy data in pharma R&D
Clinical trials for a new therapy cost a median of $41,117 per patient. Costs like this are no surprise to pharma leaders. But during an age of increasing budgetary pressures, drug developers are under pressure to do more with less money and staff. While there are no “simple” answers to this challenge, there is one strategy that offers…